## Background: We evaluated the clinical features, treatment, and survival status of the patients with borderline ovarian tumors. Methods: A retrospective review of the charts of 150 patients with borderline ovarian tumor registered at the Tokai Ovarian Tumor Study Group from January 1, 1980, to D
✦ LIBER ✦
DNA cytophotometry and prognosis in ovarian tumors of borderline malignancy. A clinicomorphologic study of 80 cases
✍ Scribed by Barbara-Christina Padberg; Hartmut Arps; Ursula Franke; Carsten Thiedemann; Wolfgang Rehpenning; Hans-Egon Stegner; Helmut Lietz; Sören Schröder; Manfred Dietel
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 490 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Clinical behavior of borderline ovarian
✍
Tamakoshi, Koji; Kikkawa, Fumitaka; Nakashima, Nobuo; Tamakoshi, Akiko; Kawai, M
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 96 KB
👁 2 views
The incidence of borderline ovarian tumo
✍
José Iscovich; Asher Shushan; Joseph G. Schenker; Ora Paltiel
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 74 KB
👁 3 views
among ethnic groups (based on ethnic group and country of birth) for the years 1985-1993.
K-ras mutations in mucinous ovarian tumo
✍
Miriam Cuatrecasas; Alberto Villanueva; Xavier Matias-Guiu; Jaime Prat
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 160 KB
👁 2 views
tissue, and target sequences were amplified in vitro by polymerase chain reaction. lona, Spain. Mutations were detected by the presence of restriction fragment length polymorphisms artificially introduced by the use of mutant amplimers. In tumors containing areas that exhibited different histologic